Poniard Pharmaceuticals Inc (OTC Pink - No Information:PARD)

0.08
Delayed Data
As of Aug 06
 0.00 / 0.00%
Today’s Change
0.01
Today|||52-Week Range
0.10
+337.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2007

2008

2009

2010
Revenue and IncomeNet Revenues0.000.000.000.00--
Cost of Goods Sold23.4M0.00--0.00
 
 
Depreciation And Amortization1.5M1.6M1.5M1.3M
 
 
 
 
 
 
Operating ExpensesGross Income-24.9M-1.6M---1.3M
 
 
 
 
General Expenses10.6M47.6M39.0M23.8M
 
 
 
 
 
Research And Development--34.7M25.7M8.0M
 
 
 
 
Total Operating Expenses35.5M49.2M40.4M25.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-35.5M-49.2M-40.4M-25.1M
 
 
 
 
 
Extraordinary Charge0.000.00-2.5M-2.8M
 
 
 
Interest Expense On Debt1.7M--3.1M2.2M
 
 
 
 
Other Expenses105.0K592.0K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-32.8M-48.6M-45.7M-30.1M
 
 
 
 
 
Preferred Dividend-500.0K-500.0K-500.0K-736.0K
 
 
 
 
 
Net Income-32.8M-48.6M-45.7M-30.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS769.1K867.2K881.8K1.2M
 
 
 
 
 
Shares To Calculate EPS Diluted769.1K867.2K881.8K1.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$43.20-$56.40-$52.40-$26.40
 
 
 
 
 
EPS Diluted-$43.20-$56.40-$52.40-$26.40